Search Results - "Evans, Dean B."

Refine Results
  1. 1

    Intratumoral Estrogens and Estrogen Receptors in Human Non–Small Cell Lung Carcinoma by Niikawa, Hiromichi, Suzuki, Takashi, Miki, Yasuhiro, Suzuki, Satoshi, Nagasaki, Shuji, Akahira, Junichi, Honma, Seijiro, Evans, Dean B, Hayashi, Shin-Ichi, Kondo, Takashi, Sasano, Hironobu

    Published in Clinical cancer research (15-07-2008)
    “…Purpose: The possible involvement of gender-dependent factors has been suggested in human non-small cell lung carcinomas (NSCLC), but their precise roles…”
    Get full text
    Journal Article
  2. 2

    Dual Inhibition of mTOR and Estrogen Receptor Signaling In vitro Induces Cell Death in Models of Breast Cancer by Boulay, Anne, Rudloff, Joelle, Ye, Jingjing, Zumstein-Mecker, Sabine, O'Reilly, Terence, Evans, Dean B, Chen, Shiuan, Lane, Heidi A

    Published in Clinical cancer research (15-07-2005)
    “…Purpose: RAD001 (everolimus), a mammalian target of rapamycin (mTOR) pathway inhibitor in phase II clinical trials in oncology, exerts potent…”
    Get full text
    Journal Article
  3. 3

    De Novo Synthesis of Estrogen in Pregnant Uterus Is Critical for Stromal Decidualization and Angiogenesis by Das, Amrita, Mantena, Srinivasa Raju, Kannan, Athilakshmi, Evans, Dean B., Bagchi, Milan K., Bagchi, Indrani C., O'Malley, Bert W.

    “…Implantation is initiated when the embryo attaches to the uterine luminal epithelium during early pregnancy. Following this event uterine stromal cells undergo…”
    Get full text
    Journal Article
  4. 4

    Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels by GEISLER, Jürgen, HELLE, Hilgegunn, EKSE, Dagfinn, DUONG, Nhat K, EVANS, Dean B, NORDBØ, Yngve, AAS, Turid, LØNNING, Per E

    Published in Clinical cancer research (01-10-2008)
    “…Purpose: To evaluate the influence of the third-generation aromatase inhibitor letrozole (Femara) on breast cancer tissue levels of estrone (E 1 ), estradiol…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole by MILLER, William R, LARIONOV, Alexey, RENSHAW, Lorna, ANDERSON, Thomas J, WALKER, John R, KRAUSE, Andreas, SING, Tobias, EVANS, Dean B, DIXON, J. Michael

    Published in Journal of clinical oncology (20-03-2009)
    “…Endocrine agents, such as letrozole, are established in the treatment of hormone-dependent breast cancer. However, response rates are only 50% to 70% in the…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Molecular response to aromatase inhibitor treatment in primary breast cancer by Mackay, Alan, Urruticoechea, Ander, Dixon, J Michael, Dexter, Tim, Fenwick, Kerry, Ashworth, Alan, Drury, Suzanne, Larionov, Alexey, Young, Oliver, White, Sharon, Miller, William R, Evans, Dean B, Dowsett, Mitch

    Published in Breast cancer research : BCR (01-01-2007)
    “…Aromatase inhibitors such as anastrozole and letrozole are highly effective suppressants of estrogen synthesis in postmenopausal women and are the most…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activity by Hong, Yanyan, Li, Hongzhi, Ye, Jingjing, Miki, Yasuhiro, Yuan, Yate-Ching, Sasano, Hironobu, Evans, Dean B, Chen, Shiuan

    Published in PloS one (30-11-2009)
    “…Immunohistochemistry is one of the most suitable methods for the detection of intratumoral aromatase in order to identify patients who may respond to aromatase…”
    Get full text
    Journal Article
  16. 16

    The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer by Lisztwan, Joanna, Pornon, Astrid, Chen, Bin, Chen, Shiuan, Evans, Dean B

    Published in Breast cancer research : BCR (01-01-2008)
    “…Endocrine-dependent, estrogen receptor positive breast cancer cells proliferate in response to estrogens, synthesized by the cytochrome p450 aromatase enzyme…”
    Get full text
    Journal Article
  17. 17

    Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast by Shibuya, Rie, Suzuki, Takashi, Miki, Yasuhiro, Yoshida, Kimako, Moriya, Takuya, Ono, Katsuhiko, Akahira, Jun-ichi, Ishida, Takanori, Hirakawa, Hisashi, Evans, Dean B, Sasano, Hironobu

    Published in Endocrine-related cancer (01-03-2008)
    “…It is well known that sex steroids play important roles in the development of invasive ductal carcinoma (IDC) of the human breast. However, biological…”
    Get full text
    Journal Article
  18. 18

    Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial by Ellis, Matthew J., Miller, William R., Tao, Yu, Evans, Dean B., Chaudri Ross, Hilary A., Miki, Yasuhiro, Suzuki, Takashi, Sasano, Hironobu

    Published in Breast cancer research and treatment (01-07-2009)
    “…Background Expression of aromatase by malignant breast epithelial cells and/or the surrounding stroma implies local estrogen production that could influence…”
    Get full text
    Journal Article
  19. 19

    Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer by LIPTON, Allan, LEITZEL, Kim, CARNEY, Walter, CHAUDRI-ROSS, Hilary A, EVANS, Dean B, ALI, Suhail M, DEMERS, Laurence, HAMER, Peter, BROWN-SHIMER, Sheryl, PIERCE, Karen, GAUR, Victor

    Published in Journal of clinical oncology (01-06-2008)
    “…To determine the effect of elevated serum TIMP-1 on the response of patients with metastatic breast cancer to an aromatase inhibitor versus tamoxifen. Five…”
    Get full text
    Journal Article
  20. 20

    Aromatase is phosphorylated in situ at serine-118 by Miller, Todd W., Shin, Incheol, Kagawa, Norio, Evans, Dean B., Waterman, Michael R., Arteaga, Carlos L.

    “…Phosphorylation of the cytochrome P450 aromatase has been proposed as a switch to rapidly modulate enzymatic activity and estrogen biosynthesis. Herein, we…”
    Get full text
    Journal Article